BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the recipient of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 3,200 shares, a growth of 10.3% from the December 15th total of 2,900 shares. Based on an average daily volume of 154,200 shares, the days-to-cover ratio is presently 0.0 days.

BriaCell Therapeutics Price Performance

NASDAQ BCTXW opened at $0.15 on Monday. The company has a 50-day moving average price of $0.31 and a 200-day moving average price of $0.27. BriaCell Therapeutics has a 52 week low of $0.11 and a 52 week high of $2.30.

About BriaCell Therapeutics

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.